SCHEMBL4750451

SCHEMBL4750451

O=C(NCc1ccc(Cl)cc1Cl)c1ccc(Br)cc1NS(=O)(=O)c1c(F)cccc1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 4/20 0.52
AKR1B1 P15121 1/20 0.48
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 2/20 0.46
MAPT P10636 2/20 0.46
LMNA P02545 2/20 0.46
HPGD P15428 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
FLT1 P17948 3/20 0.43
FLT4 P35916 3/20 0.43
KDR P35968 3/20 0.43
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
EPHX2 P34913 3/20 0.42
KDM4E B2RXH2 1/20 0.41
RCE1 Q9Y256 1/20 0.41
KCNA5 P22460 1/20 0.40
INPPL1 O15357 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4751037 0.93 LMNA (0.49) CCKBRMEN1KMT2AALDH1A1MAPT
SCHEMBL4749807 0.85 CCKBR (0.54) CCKBRAKR1B1MEN1KMT2AALDH1A1
SCHEMBL13011850 0.84 CCKBR (0.52) CCKBRCCKAR
SCHEMBL3748849 0.84 CCKBR (0.52) CCKBRCCKAR
SCHEMBL4749827 0.83 CCKBR (0.45) CCKBRAKR1B1MEN1KMT2AALDH1A1
SCHEMBL4750072 0.81 KCNA5 (0.55) CCKBRMEN1KMT2AHPGDKCNA5
SCHEMBL3744724 0.80 CCKBR (0.55) CCKBRKMT2AALDH1A1LMNAFLT1
SCHEMBL3752702 0.80 CCKAR (0.56) CCKBRMEN1KMT2AMAPTLMNA
SCHEMBL1890621 0.79 CCKBR (0.61) CCKBRCCKAR
SCHEMBL4749806 0.79 CCKBR (0.50) CCKBRMEN1KMT2AFLT1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008124524-A2 ARYL SULFONAMIDE COMPOUNDS AS MODULATORS OF THE CCK2 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2008-10-16 WO claimed
WO-2008124524-A2 ARYL SULFONAMIDE COMPOUNDS AS MODULATORS OF THE CCK2 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2008-10-16 WO disclosed